These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21682894)

  • 1. Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction.
    Wood PL; Smith T; Pelzer L; Goodenowe DB
    Lipids Health Dis; 2011 Jun; 10():102. PubMed ID: 21682894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
    Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
    Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease.
    Ruiz M; Bégou M; Launay N; Ranea-Robles P; Bianchi P; López-Erauskin J; Morató L; Guilera C; Petit B; Vaurs-Barriere C; Guéret-Gonthier C; Bonnet-Dupeyron MN; Fourcade S; Auwerx J; Boespflug-Tanguy O; Pujol A
    Brain Pathol; 2018 Sep; 28(5):611-630. PubMed ID: 29027761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.
    Inoue K
    Neurogenetics; 2005 Feb; 6(1):1-16. PubMed ID: 15627202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of 4-Phenylbutyrate against proteolipid protein mutation-induced endoplasmic reticulum stress and oligodendroglial cell death.
    Wilding AS; Patte-Mensah C; Taleb O; Brun S; Kemmel V; Mensah-Nyagan AG
    Neurochem Int; 2018 Sep; 118():185-194. PubMed ID: 29936187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
    Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
    Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease.
    Shiihara T; Watanabe M; Moriyama K; Uematsu M; Sameshima K
    Brain Dev; 2015 Apr; 37(4):455-8. PubMed ID: 25043250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ
    Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
    Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced PLP1 expression in induced pluripotent stem cells derived from a Pelizaeus-Merzbacher disease patient with a partial PLP1 duplication.
    Shimojima K; Inoue T; Imai Y; Arai Y; Komoike Y; Sugawara M; Fujita T; Ideguchi H; Yasumoto S; Kanno H; Hirose S; Yamamoto T
    J Hum Genet; 2012 Sep; 57(9):580-6. PubMed ID: 22695888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
    Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene.
    Liu B; Chen L; Sun J; Zhang L; Chen M; Qian Y; Wang Y; Yan K; Hou L; Huang Y; Zhang D; Xu Y; Yu J; Zhang J; Dong M
    Stem Cell Res; 2020 May; 45():101791. PubMed ID: 32402715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease.
    Wang JM; Wu Y; Wang HF; Deng YH; Yang YL; Qin J; Li XY; Wu XR; Jiang YW
    Chin Med J (Engl); 2008 Sep; 121(17):1638-42. PubMed ID: 19024090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.